- Home
- WRN vs TKNO Comparison
WRN vs TKNO Comparison
Compare WRN & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WRN | TKNO |
|---|---|---|
| Founded | 2006 | 1996 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Medicinal Chemicals and Botanical Products |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 452.6M | 236.6M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | WRN | TKNO |
|---|---|---|
| Price | $2.97 | $4.02 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.13 | N/A |
| AVG Volume (30 Days) | ★ 907.2K | 128.5K |
| Earning Date | 03-24-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $39,801,000.00 |
| Revenue This Year | N/A | $8.79 |
| Revenue Next Year | N/A | $10.52 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 9.50 |
| 52 Week Low | $0.90 | $3.85 |
| 52 Week High | $3.02 | $10.37 |
Technical Indicators
Market Signals| Indicator | WRN | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 78.58 | 32.65 |
| Support Level | $2.78 | $3.85 |
| Resistance Level | $2.94 | $4.86 |
| Average True Range (ATR) | 0.12 | 0.29 |
| MACD | 0.03 | -0.06 |
| Stochastic Oscillator | 90.68 | 13.76 |
Price Performance
Historical ComparisonAbout WRN Western Copper and Gold Corporation
Western Copper & Gold Corp is a Canada-based exploration-stage company. The company is engaged in the exploration and development of the Casino mineral property located in Yukon, Canada (the Casino Project).
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.